Advanced company searchLink opens in new window

SDS THERAPEUTICS LIMITED

Company number 12719780

Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
08 Jul 2024 CS01 Confirmation statement made on 4 July 2024 with no updates
14 Mar 2024 AA Accounts for a small company made up to 31 July 2023
05 Mar 2024 TM01 Termination of appointment of Francesco De Rubertis as a director on 17 January 2024
05 Mar 2024 TM01 Termination of appointment of David John Grainger as a director on 17 January 2024
06 Nov 2023 PSC08 Notification of a person with significant control statement
06 Nov 2023 PSC07 Cessation of Medicxi Iii Lp as a person with significant control on 18 December 2020
04 Jul 2023 CS01 Confirmation statement made on 4 July 2023 with no updates
10 May 2023 AA Accounts for a small company made up to 31 July 2022
05 Jul 2022 CS01 Confirmation statement made on 4 July 2022 with no updates
24 Feb 2022 AA Accounts for a small company made up to 31 July 2021
29 Oct 2021 AP04 Appointment of The Cambridge Partnership Limited as a secretary on 5 July 2020
05 Jul 2021 CS01 Confirmation statement made on 4 July 2021 with updates
02 Feb 2021 SH02 Sub-division of shares on 18 December 2020
29 Jan 2021 SH01 Statement of capital following an allotment of shares on 27 January 2021
  • GBP 573.53
28 Jan 2021 PSC02 Notification of Medicxi Iii Lp as a person with significant control on 18 December 2020
18 Jan 2021 AP01 Appointment of Professor James Huntington as a director on 18 December 2020
13 Jan 2021 AP01 Appointment of Dr Christine Janet Martin as a director on 18 December 2020
13 Jan 2021 PSC07 Cessation of David John Grainger as a person with significant control on 18 December 2020
13 Jan 2021 AP01 Appointment of Mr Francesco De Rubertis as a director on 18 December 2020
13 Nov 2020 AD01 Registered office address changed from Dorothy Hodgkin Building Babraham Research Campus Babraham Cambridge CB22 3AT United Kingdom to C/O the Cambridge Partnership Limited the Dorothy Hodgkin Building Babraham Research Campus, Babraham Cambridge CB22 3FH on 13 November 2020
05 Jul 2020 NEWINC Incorporation
  • MODEL ARTICLES ‐ Model articles adopted

Statement of capital on 2020-07-05
  • GBP 1